Technology Platform: UCD Pre-Clinical Molecular Imaging Facility [SFI-funded]
About Us
In vivo imaging of molecular events in animal models holds significant potential in areas like oncology, cardiovascular disease, neurology, diabetes, infectious disease and inflammation research. Molecular imaging is also an essential tool for translational research and new drug development, with the rapid emergence of imaging-based biomarkers. The development of multi-modality methodologies based on PET, SPECT, MRI, CT, ultrasound and optical imaging is the single biggest focus in many imaging centres worldwide.
UCD forms one of the nodes of the National Preclinical Imaging Centre. NPIC is a collaboration between the Royal College of Surgeons in Ireland (RCSI), University College Dublin (UCD) and The National University of Ireland – Galway (NUIG).
The Centre, which is the first of its kind in Ireland, will use its imaging infrastructure to support the development of new therapeutics and diagnostics in human disease areas including cancer, neurology, dementia, psychiatry, cardiology, medical devices, diabetes, tissue engineering, nanomedicine and inflammatory disease. The Centre will provide a national pre-clinical imaging resource open to all academic, industry and not-for-profit researchers, and will have locations in Dublin (RCSI, UCD) and Galway (NUI Galway). NPIC establishes a national pre-clinical magnetic resonance (MR) facility, a national high-field preclinical MR / chemical imaging platform and incorporates a high-resolution micro-computed tomography (CT) and Optical Imaging laboratory.
UCD
Services, Expertise and Training
Contact
For general enquires, including collaborative research studies, contact Prof. William Gallagher (william.gallagher@ucd.ie) for further details.
For technical details relating to optical, microCT and MRI imaging systems, contact Ms. Emer Conroy (emer.conroy@ucd.ie).
